aspirin has been researched along with tricalcium phosphate in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, KA; Rhodes, CT | 1 |
| Fraser, DR | 1 |
| Fraser, DR; Ganderton, D | 1 |
| Garcia, F; Moskowitz, RW | 1 |
| Duvall, RN; Gold, G; Hurtle, RL; Palermo, BT | 1 |
| Kennedy, DR; McGee, BJ; Walker, GC | 1 |
| Duvall, RN; Gold, G; Palermo, BT; Slater, JG | 1 |
| Contractor, AM; Kim, HY; Manudhane, KS; Shangraw, RF | 1 |
| Bolhuis, GK; Lerk, CF; Smallenbroek, AJ | 1 |
| Bajpai, PK; Moldovan, KM | 1 |
| Fox, JL; Higuchi, WI; Matsuda, Y; Otsuka, M; Suwa, Y | 1 |
| Chandy, T; Sharma, CP; Vasudev, SC | 1 |
| PRIEN, EL; WALKER, BS | 1 |
| Fontao, MJ; Landín, M; Martínez-Pacheco, R | 1 |
| Aldous, B; Auffret, T; Cassidy, AM; Gardner, CE; Jones, W | 1 |
| Chen, Y; Fang, X; Jiang, T; Kang, Y; Lei, L | 1 |
| Liao, W; Tao, ZS; Wu, XJ; Xu, HG; Yang, L; Yang, M; Zhou, WS | 1 |
| Heng, PWS; Liew, CV; Veronica, N | 1 |
| Tao, ZS; Xu, HG; Yang, M; Zhou, WS | 1 |
| Lee, J; Sinha, S; Su, N; Villicana, C; Yang, A; Yang, F; Zhang, C | 1 |
20 other study(ies) available for aspirin and tricalcium phosphate
| Article | Year |
|---|---|
Effect of compaction on particle size.
Topics: Aluminum; Aspirin; Calcium Phosphates; Carbonates; Cellulose; Oxides; Particle Size; Pressure; Tablets | 1975 |
An investigation of some of the factors influencing tablet strength.
Topics: Aspirin; Calcium Phosphates; Carbonates; Lactose; Magnesium; Particle Size; Phenindione; Pressure; Starch; Sucrose; Tablets | 1972 |
Some observations of the penetration and disruption of tablets by water.
Topics: Aspirin; Calcium Phosphates; Carbonates; Lactose; Magnesium; Permeability; Phenindione; Powders; Pressure; Starch; Sucrose; Surface Tension; Tablets; Technology, Pharmaceutical; Water | 1970 |
Chondrocalcinosis articularis (pseudogout syndrome).
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Antinuclear; Arthritis, Rheumatoid; Aspirin; Blood Sedimentation; Calcinosis; Calcium Phosphates; Cartilage, Articular; Chondrocalcinosis; Colchicine; Crystallization; Diagnosis, Differential; Female; Gout; Humans; Indomethacin; Joint Diseases; Male; Middle Aged; Phenylbutazone; Radiography; Synovial Fluid; Uric Acid | 1973 |
Granule strength as a formulation factor I: instrumentation.
Topics: Aspirin; Biomedical Engineering; Calcium Phosphates; Carbohydrates; Drug Compounding; Powders | 1971 |
Some factors affecting release and availability of drugs from hard gelatin capsules.
Topics: Analysis of Variance; Aspirin; Biopharmaceutics; Calcium Phosphates; Capsules; Gastric Juice; Gelatin; Lactose; Solubility; Time Factors | 1970 |
Powder flow studies. IV. Uniformity of flow: Instrumentation and applications.
Topics: Aspirin; Calcium Phosphates; Drug Compounding; Methods; Pharmacopoeias as Topic; Powders; Tablets | 1968 |
Tableting properties of a directly compressible starch.
Topics: Aspirin; Calcium Phosphates; Drug Compounding; Drug Stability; Lactose; Pharmaceutic Aids; Solubility; Starch; Tablets; Time Factors | 1969 |
Interaction of tablet disintegrants and magnesium stearate during mixing I: Effect on tablet disintegration.
Topics: Aspirin; Calcium Phosphates; Drug Compounding; Excipients; Hardness; Lactose; Solubility; Starch; Stearic Acids; Tablets | 1981 |
A ceramic system for continuous release of acetylsalicylic acid.
Topics: Aspirin; Calcium Phosphates; Ceramics; Drug Implants | 1994 |
A novel skeletal drug-delivery system using self-setting calcium phosphate cement. 4. Effects of the mixing solution volume on the drug-release rate of heterogeneous aspirin-loaded cement.
Topics: Aspirin; Bone and Bones; Bone Cements; Calcium Phosphates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Fourier Analysis; Hardness; Hydroxyapatites; Porosity; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; X-Ray Diffraction | 1994 |
Glutaraldehyde treated bovine pericardium: changes in calcification due to vitamins and platelet inhibitors.
Topics: Animals; Ascorbic Acid; Aspirin; Biological Transport; Bioprosthesis; Calcinosis; Calcium; Calcium Phosphates; Cattle; Dipyridamole; Drug Combinations; Fixatives; Glutaral; Microscopy, Electron, Scanning; Pericardium; Platelet Aggregation Inhibitors; Pyridoxine; Vitamin E; Vitamins | 1997 |
Studies in urolithiasis. IV. Urinary glucuronosides and calcium phosphate.
Topics: Aspirin; Biliary Tract; Biliary Tract Diseases; Calcium Phosphates; Calculi; Humans; Kidney; Kidney Calculi; Salicylates; Urolithiasis | 1955 |
A comparison of trehalose dihydrate and mannitol as stabilizing agents for dicalcium phosphate dihydrate based tablets.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Phosphates; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Stability; Drug Storage; Mannitol; Sweetening Agents; Tablets; Trehalose | 2005 |
Decoupling the effects of surface chemistry and humidity on solid-state hydrolysis of aspirin in the presence of dicalcium phosphate dihydrate.
Topics: Aspirin; Calcium Phosphates; Drug Stability; Humidity; Hydrolysis; Microscopy, Atomic Force; Surface Properties | 2012 |
Injectable thermosensitive alginate/β-tricalcium phosphate/aspirin hydrogels for bone augmentation.
Topics: Acrylic Resins; Alginates; Animals; Aspirin; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Humans; Hydrogels; Male; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Skull; X-Ray Microtomography | 2018 |
Local administration of aspirin with β-tricalcium phosphate/poly-lactic-co-glycolic acid (β-TCP/PLGA) could enhance osteoporotic bone regeneration.
Topics: Animals; Aspirin; Biomarkers; Biomechanical Phenomena; Bone Regeneration; Calcium Phosphates; Disease Models, Animal; Female; Femur; Neovascularization, Physiologic; Osteogenesis; Osteoporosis; Ovariectomy; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; RNA, Messenger; X-Ray Microtomography | 2019 |
Insights on the role of excipients and tablet matrix porosity on aspirin stability.
Topics: Aspirin; Calcium Phosphates; Cellulose; Chemistry, Pharmaceutical; Drug Compounding; Excipients; Porosity; Pressure; Starch; Tablets; Tensile Strength; Water | 2020 |
Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats.
Topics: 3T3 Cells; Animals; Anti-Inflammatory Agents; Aspirin; Bone Density; Bone Morphogenetic Protein 2; Bone Remodeling; Bone Substitutes; Calcium Phosphates; Disease Models, Animal; Female; Femur; Humans; Mice; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Osteoprotegerin; Ovariectomy; RANK Ligand; Rats, Sprague-Dawley; Signal Transduction; Smad1 Protein; Strontium; Wound Healing | 2020 |
Aspirin synergizes with mineral particle-coated macroporous scaffolds for bone regeneration through immunomodulation.
Topics: Aspirin; Bone Regeneration; Bone Resorption; Culture Media, Conditioned; Gelatin; Humans; Immunomodulation | 2023 |